-
Markerless Kinematic Analysis of Gait and Turning in Parkinson’s Disease
-
Markerless Kinematics of Levodopa Response During Activities of Daily Living in Parkinson’s Disease
-
Mass balance and metabolism of BIA 28-6156, an allosteric activator of beta-glucocerebrosidase, in humans
-
MDS Guidance Framework for Electronic Clinical Outcome Assessments: Updating Practices for Validation and Implementation
-
MDS-UPDRS Part III Cannot Be Reliably Reduced for Prognostic Modeling in Early Parkinson’s Disease
-
MDSGene literature update on autosomal recessive Parkinson’s Disease
-
Mechanical Ventilation Modifies the Natural History of DCTN1 p.G71A Perry Disease: A 20-Year Longitudinal Study
-
Mechanisms of PLA2G6 Deficiency Impacting Mitochondria-associated membranes in Parkinson’s Disease
-
Mechanistic study of PARP9-mediated mitochondrial transfer in regulating dopaminergic neuronal injury and neuroinflammation in Parkinson’s disease
-
Medical Management of Late-stage Parkinson’s Disease – a Cross-sectional, Multinational Survey
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 208
- Next Page »
